SamsungBioepisLaunchesUstekinumabBiosimilar,MarkingItsFirstProductLaunchinJapan
===2026/5/20 10:02:52===
1 Stelara is a trademark of Johnson & Johnson.
2 Ustekinumab BS 45 mg Syringe for S.C. Injection「NIPRO」 is not indicated for the treatment of Crohn's disease or ulcerative colitis.
3 Samsung Bioepis’s ustekinumab biosimilar is available under the brand name PYZCHIVA™ in the EU, the UK, and the US. In Korea, it is available under the brand name EPYZTEK™.
Contacts
MEDIA CONTACT
Anna Nayun Kim, nayun86.kim@samsung.com
Yoon Kim, yoon1.kim@samsung.com
=*=*=*=*=*=
当前为第4/4页
上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页